Dexcom Inc (NASDAQ:DXCM)
| 527.04 BATS BZX Real-Time Price As of 11:07am ET |  +7.53 / +1.45%Today’s Change | 318.45 Today|||52-Week Range 659.45 | +42.55% Year-to-Date |
Latest DXCM News | Press Releases
No recent news for Dexcom Inc.
Today’s Trading
| Previous close | 519.51 |
| Today’s open | 518.36 |
| Day’s range | 512.53 - 530.37 |
| Volume | 17,670 |
| Average volume (3 months) | 607,281 |
| Market cap | $54.3B |
Data as of 11:07am ET, 12/06/2021
Growth & Valuation
| Earnings growth (last year) | +371.15% |
| Earnings growth (this year) | -8.39% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +30.54% |
| P/E ratio | 98.1 |
| Price/Sales | 18.71 |
| Price/Book | 29.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +1.56 | +3.95% |
| BAXBaxter International... | +2.39 | +3.06% |
| WSTWest Pharmaceutical ... | -3.44 | -0.79% |
| BDXBecton Dickinson and... | +4.54 | +1.86% |
Data as of 11:08am ET, 12/06/2021
Financials
| Next reporting date | February 23, 2022 |
| EPS forecast (this quarter) | $0.89 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $493.6M |
| Net profit margin | 25.62% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
